Open Access4th International Kyoto Liver Cancer Symposium: Emerging Strategies to HCC. Kyoto, Japan, June 7-8, 2014: Abstracts
Author(s) -
Masatoshi Kudo
Publication year - 2014
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000343869
Subject(s) - medicine , kyoto protocol , environmental health , greenhouse gas , biology , ecology
GIDEON is a global, prospective, non-interventional study evaluating patients with unresectable hepatocellular carcinoma (uHCC) treated with sorafenib in clinical practice. Completion of GIDEON created a large database of >3000 sorafenib-treated patients across 39 countries and 5 regions, allowing for assessment of regional differences in treatment history, practices, and outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom